Erythromycin A enol ether

Erythromycin A enol ether is an acidic degradation product of Erythromycin A (macrolide antibiotic) and has no antibacterial effect[1][2].

Product Specifications

CAS Number

[33396-29-1]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Antibiotic

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/erythromycin-a-enol-ether.html

Purity

98.86

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

C[C@@](OC([C@@H]([C@H]([C@](O)1C)O)C)=C2C)(C2)[C@@H]([C@H]([C@@H]([C@H](C(O[C@@H]1CC)=O)C)O[C@H](O[C@H]3C)C[C@](C)([C@H]3O)OC)C)O[C@H](O[C@@H]4C)[C@@H]([C@H](C4)N(C)C)O

Molecular Formula

C37H65NO12

Molecular Weight

715.91

Precautions

H302, H315, H319, H335

References & Citations

[1]A Deubel, et al. Development of an enhanced separation of erythromycin and its related substances by liquid chromatography. J Pharm Biomed Anal. 2007 Jan 17;43 (2) :493-8.|[2]Abdolreza Hassanzadeh, et al. Mechanism for the degradation of erythromycin A and erythromycin A 2'-ethyl succinate in acidic aqueous solution. J Phys Chem A. 2007 Oct 11;111 (40) :10098-104.